|
1
|
Liotta EM, Batra A, Clark JR, Shlobin NA,
Hoffman SC, Orban ZS and Koralnik IJ: Frequent neurologic
manifestations and encephalopathy-associated morbidity in Covid-19
patients. Ann Clin Transl Neurol. 7:2221–2230. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pezzini A and Padovani A: Lifting the mask
on neurological manifestations of COVID-19. Nat Rev Neurol.
16:636–644. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Frontera JA, Sabadia S, Lalchan R, Fang T,
Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A,
et al: A prospective study of neurologic disorders in hospitalized
patients with COVID-19 in New York City. Neurology. 96:e575–e586.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cilia R, Bonvegna S, Straccia G, Andreasi
NG, Elia AE, Romito LM, Devigili G, Cereda E and Eleopra R: Effects
of COVID-19 on Parkinson's disease clinical features: A
Community-based case-control study. Mov Disord. 35:1287–1292.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Angelopoulou E, Karlafti E, Georgakopoulou
VE, Papalexis P, Papageorgiou SG, Tegos T and Savopoulos C:
Exploring the Role of ACE2 as a Connecting Link between COVID-19
and Parkinson's Disease. Life (Basel). 13(536)2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bougea A, Georgakopoulou VE, Palkopoulou
M, Efthymiopoulou E, Angelopoulou E, Spandidos DA and Zikos P:
New-onset non-motor symptoms in patients with Parkinson's disease
and post-COVID-19 syndrome: A prospective cross-sectional study.
Med Int. 3(23)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Putri C, Hariyanto TI, Hananto JE,
Christian K, Situmeang RFV and Kurniawan A: Parkinson's disease may
worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia
in hospitalized patients: A systematic review, meta-analysis, and
meta-regression. Parkinsonism Relat Disord. 87:155–161.
2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
McLean G, Hindle JV, Guthrie B and Mercer
SW: Co-morbidity and polypharmacy in Parkinson's disease: Insights
from a large Scottish primary care database. BMC Neurol.
17(126)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Richter D, Bartig D, Krogias C and Tönges
L: Letter to the editor: Risk comorbidities of COVID-19 in
Parkinson's disease patients in Germany. Neurol Res Pract.
2(22)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fasano A, Cereda E, Barichella M, Cassani
E, Ferri V, Zecchinelli AL and Pezzoli G: COVID-19 in Parkinson's
Disease Patients Living in Lombardy, Italy. Mov Disord.
35:1089–1093. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Scherbaum R, Kwon EH, Richter D, Bartig D,
Gold R, Krogias C and Tönges L: Clinical profiles and mortality of
COVID-19 inpatients with parkinson's disease in Germany. Mov
Disord. 36:1049–1057. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Parihar R, Ferastraoaru V, Galanopoulou
AS, Geyer HL and Kaufman DM: Outcome of hospitalized Parkinson's
disease patients with and without COVID-19. Mov Disord Clin Pract.
8:859–867. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fathi M, Taghizadeh F, Mojtahedi H, Zargar
Balaye Jame S and Markazi Moghaddam N: The effects of Alzheimer's
and Parkinson's disease on 28-day mortality of COVID-19. Rev Neurol
(Paris). 178:129–136. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Salari M, Etemadifar M, Ashrafi F, Ommi D,
Aminzade Z and Tehrani Fateh S: Parkinson's disease patients may
have higher rates of Covid-19 mortality in Iran. Parkinsonism Relat
Disord. 89:90–92. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Scorza FA, Fiorini AC, Scorza CA and
Finsterer J: Cardiac abnormalities in Parkinson's disease and
Parkinsonism. J Clin Neurosci. 53:1–5. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Baille G, Chenivesse C, Perez T, Machuron
F, Dujardin K, Devos D, Defebvre L and Moreau C: Dyspnea: An
underestimated symptom in Parkinson's disease. Parkinsonism Relat
Disord. 60:162–166. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bugalho P, Ladeira F, Barbosa R, Marto JP,
Borbinha C, Salavisa M, da Conceição L, Saraiva M, Fernandes M and
Meira B: Motor and non-motor function predictors of mortality in
Parkinson's disease. J Neural Transm (Vienna). 126:1409–1415.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Okunoye O, Kojima G, Marston L, Walters K
and Schrag A: Factors associated with hospitalisation among people
with Parkinson's disease-A systematic review and meta-analysis.
Parkinsonism Relat Disord. 71:66–72. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dementia in parkinsonism. Ann Indian Acad
Neurol. 14 (Suppl 1):S21–S14. 2011.PubMed/NCBI
|
|
20
|
Kostev K, Gessler N, Wohlmuth P, Arnold D,
Bein B, Bohlken J, Herrlinger K, Jacob L, Koyanagi A, Nowak L, et
al: Is Dementia associated with COVID-19 mortality? A multicenter
retrospective cohort study conducted in 50 hospitals in Germany. J
Alzheimers Dis. 91:719–726. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mathioudakis N, Zachiotis M, Papadakos S,
Triantafyllou M, Karapanou A, Samara S, Karamanakos G, Spandidos
DA, Papalexis P, Damaskos C, et al: Onodera's prognostic
nutritional index: Comparison of its role in the severity and
outcomes of patients with COVID-19 during the periods of alpha,
delta and omicron variant predominance. Exp Ther Med.
24(675)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sun S, Wen Y and Li Y: Serum albumin,
cognitive function, motor impairment, and survival prognosis in
Parkinson disease. Medicine (Baltimore). 101(e30324)2022.PubMed/NCBI View Article : Google Scholar
|
